Design Therapeutics, Inc. (NASDAQ:DSGN) Investor Alert: Investigation Concerning Possible Wrongdoing
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Design Therapeutics, Inc.
View full press release